Industry News

May 28, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Johnson & Johnson acquires Cougar Biotechnology; NIH launches program for rare and neglected diseases; PPD restructures leadership positions; more...
May 21, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO; more...
May 14, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president and CEO; more...
May 07, 2009
By Pharmaceutical Technology Editors
A "rigorous" review of its R&D portfolio has led sanofi aventis to axe the development of 14 drugs/projects; four of which were in Phase III development.
May 07, 2009
By Pharmaceutical Technology Editors
An agreement between Bayer HealthCare and Ardea Biosciences Inc. will focus on the development of MEK inhibitors for the treatment of cancer.
May 07, 2009
By Pharmaceutical Technology Editors
Pharmaceutical companies must make bold moves and "step outside of their sector" if they are to survive.
May 07, 2009
By Pharmaceutical Technology Editors
The UK's Specials Laboratory, a manufacturer of unlicensed or 'special' medicines, has set its sights on expansion after reporting a 30% growth in turnover.
May 07, 2009
By Pharmaceutical Technology Editors
As the panic surrounding swine flu continues to escalate, Roche and GlaxoSmithKline (GSK), whose flu medicines Tamiflu and Relenza, respectively, have been in great demand since the outbreak in Mexico, have taken action to prevent hoarding.
May 07, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for botulinum toxin producs; C. Richter King joins IAVI; more...
May 01, 2009
Pharmaceutical Technology Europe PTE
By Pharmaceutical Technology Editors
Vietnam's pharmaceutical sector has huge growth potential, but are conditions ideal for foreign players to unearth the country's hidden opportunities?
native1_300x100
lorem ipsum